PTC Therapeutics, Inc. Capex/Depreciation

Capex/Depreciation of PTCT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending June 30, 2022 was -0.28 (a -90.45% decrease compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation decreased by -89.24%
  • Annual Capex/Depreciation for 2021 was -1.19 (a 5.66% increase from previous year)
  • Annual Capex/Depreciation for 2020 was -1.13 (a -10.81% decrease from previous year)
  • Annual Capex/Depreciation for 2019 was -1.27 (a 112.68% increase from previous year)
  • Twelve month Capex/Depreciation ending June 30, 2022 was -0.33 (a -84.18% decrease compared to previous quarter)
  • Twelve month trailing Capex/Depreciation decreased by -82.33% year-over-year
Trailing Capex/Depreciation for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-0.33 -2.08 -1.57 -1.86
Visit stockrow.com/PTCT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of PTC Therapeutics, Inc.

Most recent Capex/Depreciationof PTCT including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of PTC Therapeutics, Inc.

PTC Therapeutics, Inc. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.28 -2.89
2021 -1.16 -2.56 -0.47 -1.29 -1.19
2020 -1.38 -2.38 -0.04 -1.91 -1.13
2019 -1.79 -1.6 -1.94 -0.41 -1.27
2018 -1.34 -0.73 -0.11 -0.08 -0.6
2017 -12.97 -0.05 -0.32 -0.25 -4.54
2016 -1.06 -0.19 -0.01 -0.17 -0.32
2015 -0.47 -0.49 -0.26 -0.79 -0.5
2014 -3.8 -0.37 -0.62 -0.19 -1.21
2013 -0.64 -0.64 -0.13 -0.03 -0.35
2012 0.01 -0.01 -0.03 -0.23 -0.07
2011 -0.06 -0.06

Business Profile of PTC Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology